中西医结合抗肝纤维化的研究思路与方法(4)
[2] Bruix J， Poynard T， Colombo M， et al. Maintenance therapy with Peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C[J]. Gastroenterology， 2011， 140(7)： 1990-1999.[3] Papatheodoridis GV， Manolakopoulos S， Touloumi G， et al. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy： results of the nationwide HEPNET. Greece cohort study[J]. Gut ......
您现在查看是摘要页，全文长 3031 字符。